May 18, 2017 – 8 a.m. – 4 p.m. – Hilton Baltimore
Join Governor Hogan for the first Maryland Governor’s Business Summit. Explore topics on human capital, global trends and business strategy. Connect with a wide array of Maryland’s business leaders.
Newsflash: The Association of University Technology Managers met in Hollywood, Fla., and had its own Final Four last week.
All of the finalists of the conference’s pitch competition had a common bond: They each had ties to Maryland universities such as Johns Hopkins and University of Maryland. All four also received funding from TEDCO’s Maryland Innovation Initiative.
The University of Maryland, Baltimore (UMB) today announced the appointment of Marco Chacón, PhD, as Assistant Vice President, Industry Alliances. In this role, Dr. Chacón, a seasoned biopharmaceutical executive and entrepreneur, will work with the Office of Research and Development, UM Ventures, and University of Maryland BioPark teams, leading special projects to grow the BioPark tenant base and strengthen the University’s research collaborations with industry.
“Marco is a distinguished scientist, entrepreneur, and biopharma CEO who has spent many years working as a valued member of the UM BioPark community,” said James L. Hughes, Vice President and Chief Enterprise & Economic Development Officer and president of the corporation that manages the UM BioPark. “His accomplishments leading a successful contract development and manufacturing organization, along with his deep industry and government connections, make him a superb addition to our team at UMB.
Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, today announced that it has signed a definitive agreement under which Pharmaron will acquire a majority stake in Shin Nippon Biomedical Laboratories Clinical Pharmacology Center, Inc. (“SNBL CPC”) in Baltimore, Maryland, USA. This clinical center is a leading provider of moderate and highly complex Phase I/II clinical development services for the life sciences sector. Current shareholder Shin Nippon Biomedical Laboratories, Ltd. (SNBL) (TSE:2395) will retain a minority stake in the business following the transaction.
On an afternoon in early February, Richard May, the head of a new Baltimore nonprofit, stands braced against the wind and sketches out a vision for West Baltimore. It begins here, on a blighted section of North Avenue not far from the Maryland Institute College of Art, where a graveyard of a public housing project, unoccupied for almost two years, is currently being torn down.
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a two-year contract with the Biomedical Advanced Research and Development Authority (BARDA), a division within the Office of the Assistant Secretary of Preparedness and Response, valued at $100 million for the delivery of BioThrax® (Anthrax Vaccine Adsorbed) to the Strategic National Stockpile (SNS). This contract satisfies BARDA’s notice of intent to sole source BioThrax that was issued on December 8, 2016 and is separate from and in addition to the company’s $911 million BioThrax procurement contract with the Centers for Disease Control and Prevention (CDC). BioThrax pricing under this BARDA procurement contract is the same as BioThrax pricing under the CDC follow-on contract.
“Emergent is pleased to support BARDA in its efforts to enhance the nation’s preparedness against the threat of anthrax,” said Adam Havey, executive vice president and president biodefense division at Emergent BioSolutions. “Emergent is committed to developing and manufacturing preparedness solutions that address our customers’ needs to protect against a broad spectrum of public health threats.”
Monday, April 3, 2017 11:00 AM – 6:00 PM EDT
SMC Campus Center 621 West Lombard Street Elm Room A & B Baltimore, MD 21201
The Entrepreneurship and Innovation Network (EIN) is pleased to present the 1st annual Entrepreneurship and Innovation Expo at University of Maryland, Baltimore.
Join us for a half day event celebrating all of the entrepreneurial and innovative endeavors at UMB. Events will include talks entrepreneurs at the student, faculty and student levels as well as a keynote presentation from the UMB Presidents White Paper Fellows. Other events will include tabling sessions from local entrepreneurial entities and groups.
The 2017 Maryland Incubator Company of the Year Awards publicly recognizes achievements by current clients and graduates of Maryland incubators and provides a forum for the nominees to increase their visibility in the business, technology and investment communities.
Business incubators support new and early-stage businesses in Maryland. In 1986, the first public incubator was established at the University of Maryland in College Park. Recognizing the economic challenges facing new companies, business incubators are facilities that provide reasonable market rents, shared services and technical assistance to start-ups and early-stage companies, including manufacturing, biotech, service and technology firms.
A growing tech industry is often considered the ultimate sign of a healthy local economy. By that measure, the Bay Area still stands at the top of the heap in the United States, but our survey of the metropolitan areas with the strongest tech job growth turns up some surprising places not usually thought of as tech meccas.
University of Maryland receives $1.5 million to create health care innovation center – Baltimore Sun
A pair of medicine and nursing alumni have made a $1.5 million gift to the University of Maryland’s Health Science & Human Services Library to establish a health care innovation center.
The center intends to provide an encouraging environment where doctors, medical students, nurses and other practitioners think in new ways about how to improve the doctor-patient relationship as a means of improving health care delivery, according to university officials who announced the funding Thursday.